Skip to main content
  • DE
  • EN
  • FR
Paul Scherrer Institut (PSI) Paul Scherrer Institut (PSI)
Suche
Paul Scherrer Institut (PSI) Paul Scherrer Institut (PSI)

Hauptnavigation

  • Labs & User ServicesOpen mainmenu item
    • Overview
    • Research at PSI
    • Research Divisions and Labs
    • Facilities and Instruments
    • Research Initiatives
    • PSI User Labs
    • Scientific Highlights
    • Scientific Events
    • Scientific Career
    • Useroffice
  • VisitorsOpen mainmenu item
    • Overview
    • Contact
    • How to find us
    • Public Events
    • Visitor Centre psi forum
    • Schülerlabor iLab
    • Center for Proton Therapy
  • IndustryOpen mainmenu item
    • Overview
    • Technology Transfer
    • Spin-off Companies
    • PARK innovAARE
  • Our ResearchOpen mainmenu item
    • Current topics from our research
    • Matter and Material
    • Human Health
    • Energy and Environment
    • Large Research Facilities
    • Brochures
    • Films
    • Media Corner
  • Career & Further EducationOpen mainmenu item
    • Job Opportunities
    • Personnel Policy
    • Working at PSI
    • Equal Opportunities, Diversity & Inclusion
    • Training and Further Education
    • Vocational Training
    • PSI Education Centre
    • Support Program "PSI Career Return Program"
    • PSI-FELLOW/COFUND
  • About PSIOpen mainmenu item
    • PSI in brief
    • Strategy
    • Guiding principles
    • Facts and figures
    • Organisational structure
    • Suppliers and customers
    • Customers E-Billing
    • IT and Computing
    • Safety at PSI (in German)

You are here:

  1. PSI Home
  2. Labs & User Services
  3. PSD
  4. COVID-19
  5. COVID-19 Highlights

Secondary navigation

Photon Science Division

  • COVID-19 Expanded submenu item
    • Publications
    • Rapid Access
    • COVID-19 Highlights
    • Research Areas
      • MX Beamlines
      • X-ray Imaging for Biomedicine: Lung Imaging
      • Photonics for Biomedicine
      • Molecular Biology
      • Micro- and Nanofabrication for Biosensing
      • Testing of asymptomatic individuals for fast feedback-control of COVID-19 pandemics
      • Laboratory for Scientific Computing and Modelling COVID-19 questions
  • About PSD
    • Organisational Structure
    • Photon Science Advisory Committee
  • People
  • Laboratories
  • Facilities
  • Industrial Services
  • Projects
    • ERC Synergy project HERO: Hidden Entangled and Resonating Orders
    • SLS 2.0
  • European and International Collaborations
    • BEATS
    • CALIPSOplus
    • ExPaNDS
    • LEAPS
    • Lightsources
  • Scientific Highlights and News
  • Publications

COVID-19 Highlights

31 August 2020
May Sharpe

A question of binding

Research Using Synchrotron Light Large Research Facilities Biology Human Health

At PSI, researchers are screening molecule fragments to see if these bind to important proteins of the coronavirus SARS-CoV-2 and thus have the potential to disable it. They are hoping the many individual pieces of information will yield an answer as to what an effective drug might look like.

Read more
30 July 2020
Dr. May Elizabeth Sharpe

Covid-19 research: Anti-viral strategy with double effect

Research Using Synchrotron Light Biology Human Health

Frankfurt scientists identify a possible weakness of the SARS-CoV-2 virus. They carried out part of their measurements at PSI's Swiss Light Source SLS. The research results are published this week in the scientific journal Nature.

Read more
15 May 2020
Dikic lab

First MX results of the priority COVID-19 call

The Dikic group at the Goethe University in Frankfurt am Main, Germany has published the first results following the opening of the "PRIORITY COVID-19 Call” at SLS. 

Read more
31 March 2020
covid-19

SLS MX beamtime update

Update of the SLS MX beamline operation during the COVID-19 period

Read more
21 January 2021
COVID call

Priority access call for work on combating COVID-19 continues

On January 30th, 2020, the WHO declared the recent outbreak of coronavirus disease 2019 (COVID-19), a public health emergency of international concern. It declared that there is an urgent need to improve our understanding of the newly identified virus and its possible future evolution as well as to contain the spread; to develop precise diagnostics and treatment, and to improve the public health response and patient care.

The COVID priority access call continues and is still open in 2021.

Read more

Sidebar

top

Footer

Paul Scherrer Institut

Forschungsstrasse 111
5232 Villigen PSI
Switzerland
How to find us

Imprint
Terms and Conditions

Login

Telephone: +41 56 310 21 11
Telefax: +41 56 310 21 99
Contact form

Visitor Centre psi forum
School Lab iLab (in German)
Center for Proton Therapy

Follow us: Twitter (in English) LinkedIn Youtube Issuu RSS

Quicklinks

  • Phone Book/People Search
  • Digital User Office
  • Technology transfer
  • PSI Publications
  • Computing
  • Safety (in German)
  • Job Opportunities
  • Vocational Training (in German)
  • Suppliers
  • Customers E-Billing
  • PSI Guest House
  • PSI Gastronomie (in German)

For the media

  • Media Contact
  • Media Releases
  • Social Media Newsroom
  • Facts and Figures
  • PSI in brief
  • Films
  • DE
  • EN
  • FR